Core Viewpoint - The announcement details a capital injection agreement by Baiguoyuan Group, where two individuals will invest in the company, resulting in a dilution of the company's ownership stake in its subsidiary [1] Group 1: Capital Injection Agreement - Baiguoyuan Group has entered into a capital injection agreement on February 2, 2026, with Tian Xiqiu and Lai Xianyang agreeing to invest in Baiguoyuan Commercial Management at a price of RMB 1.0 per share [1] - Tian Xiqiu will contribute RMB 660,000 and Lai Xianyang will contribute RMB 300,000 in cash to the registered capital of Baiguoyuan Commercial Management [1] - After the completion of the capital injection, Tian Xiqiu and Lai Xianyang will hold approximately 33.67% and 15.31% of the equity in Baiguoyuan Commercial Management, respectively [1] Group 2: Ownership Structure - Following the capital injection, Baiguoyuan Group's ownership stake in Baiguoyuan Commercial Management will be diluted from 100% to 51.02% [1] - Baiguoyuan Commercial Management will continue to be a subsidiary of Baiguoyuan Group, and its financial performance will still be consolidated into the financial statements of the company [1]
百果园集团(02411.HK)引入战略投资者 百果园商业管理持股摊薄至51%